These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32028328)

  • 41. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
    Lupo KB; Matosevic S
    J Hematol Oncol; 2020 Jun; 13(1):76. PubMed ID: 32532329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.
    Parato KG; Kumar A; Badley AD; Sanchez-Dardon JL; Chambers KA; Young CD; Lim WT; Kravcik S; Cameron DW; Angel JB
    AIDS; 2002 Jun; 16(9):1251-6. PubMed ID: 12045490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
    Stanietsky N; Simic H; Arapovic J; Toporik A; Levy O; Novik A; Levine Z; Beiman M; Dassa L; Achdout H; Stern-Ginossar N; Tsukerman P; Jonjic S; Mandelboim O
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17858-63. PubMed ID: 19815499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
    Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
    Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
    J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
    Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Control of the HIV-1 DNA Reservoir Is Associated
    Marras F; Casabianca A; Bozzano F; Ascierto ML; Orlandi C; Di Biagio A; Pontali E; Dentone C; Orofino G; Nicolini L; Taramasso L; Magnani M; Marincola FM; Wang E; Moretta L; De Maria A
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
    Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
    PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
    Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune checkpoint markers and anti-CD20-mediated NK cell activation.
    Wang Z; Weiner GJ
    J Leukoc Biol; 2021 Oct; 110(4):723-733. PubMed ID: 33615552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural killer cell phenotype is altered in HIV-exposed seronegative women.
    Zhao NQ; Vendrame E; Ferreira AM; Seiler C; Ranganath T; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
    PLoS One; 2020; 15(9):e0238347. PubMed ID: 32870938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir.
    Holder KA; Grant MD
    Front Cell Infect Microbiol; 2020; 10():175. PubMed ID: 32432050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.
    Liu S; Zhang H; Li M; Hu D; Li C; Ge B; Jin B; Fan Z
    Cell Death Differ; 2013 Mar; 20(3):456-64. PubMed ID: 23154388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
    Yao D; Xu L; Liu L; Zeng X; Zhong J; Lai J; Zheng R; Jin Z; Chen S; Zha X; Huang X; Lu Y
    Biomed Res Int; 2020; 2020():9531549. PubMed ID: 33102599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.
    Stanietsky N; Rovis TL; Glasner A; Seidel E; Tsukerman P; Yamin R; Enk J; Jonjic S; Mandelboim O
    Eur J Immunol; 2013 Aug; 43(8):2138-50. PubMed ID: 23677581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
    Nagumo Y; Iguchi-Manaka A; Yamashita-Kanemaru Y; Abe F; Bernhardt G; Shibuya A; Shibuya K
    PLoS One; 2014; 9(11):e112415. PubMed ID: 25384044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.